期刊
MOLECULAR PSYCHIATRY
卷 26, 期 1, 页码 80-91出版社
SPRINGERNATURE
DOI: 10.1038/s41380-020-00864-7
关键词
-
资金
- Novo Nordisk Foundation [NNF16OC0019856]
- National Natural Science Foundation of China [31771204, 31722026]
- Open Research Fund of the State Key Laboratory of Cognitive Neuroscience, Beijing Normal University
- German Research Foundation (DFG) [LI 2517/2-1, SCHE 1913/5-1]
Recent advances in human and animal research provide converging evidence for functionally relevant effects of intranasal oxytocin administration, supporting the idea that direct nose-to-brain delivery underlies the behavioral effects of oxytocin on social cognition and behavior. Furthermore, discussions on previously debated methodological issues, such as pre-registration, reproducibility, statistical power, interpretation of non-significant results, dosage, and sex differences, are integrated with suggestions for the next steps in translating intranasal oxytocin into psychiatric applications.
Reports on the modulatory role of the neuropeptide oxytocin on social cognition and behavior have steadily increased over the last two decades, stimulating considerable interest in its psychiatric application. Basic and clinical research in humans primarily employs intranasal application protocols. This approach assumes that intranasal administration increases oxytocin levels in the central nervous system via a direct nose-to-brain route, which in turn acts upon centrally-located oxytocin receptors to exert its behavioral effects. However, debates have emerged on whether intranasally administered oxytocin enters the brain via the nose-to-brain route and whether this route leads to functionally relevant increases in central oxytocin levels. In this review we outline recent advances from human and animal research that provide converging evidence for functionally relevant effects of the intranasal oxytocin administration route, suggesting that direct nose-to-brain delivery underlies the behavioral effects of oxytocin on social cognition and behavior. Moreover, advances in previously debated methodological issues, such as pre-registration, reproducibility, statistical power, interpretation of non-significant results, dosage, and sex differences are discussed and integrated with suggestions for the next steps in translating intranasal oxytocin into psychiatric applications.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据